drugset / Trial / NCT03611569
Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety of a single dose of Lu AF82422, how well it is tolerated, how the drug effects the body and what the body does to the drug in healthy non-Japanese and Japanese subjects and in patients with Parkinson's disease
Timeline
- Start
- 2018-07-25
- Primary completion
- 2021-07-26
- Completion
- 2021-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlenetug | Monoclonal antibody | — | — |